FFMMX | LGVAX | FFMMX / LGVAX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 4 years | 16 years | - |
Gain YTD | 19.246 | 21.602 | 89% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250 | 1000 | 25% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | N/A | N/A | - |
Annual Yield % from dividends | 2.16 | 1.28 | 170% |
Returns for 1 year | 26.92 | 21.47 | 125% |
Returns for 3 years | 19.97 | -5.43 | -367% |
Returns for 5 years | N/A | 34.32 | - |
Returns for 10 years | N/A | 75.56 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
MEMRX | 30.83 | 0.32 | +1.05% |
MFS Emerging Markets Equity R1 | |||
ADEIX | 17.58 | 0.03 | +0.17% |
Ancora Dividend Value Equity I | |||
JEPSX | 14.87 | 0.02 | +0.13% |
JPMorgan Equity Premium Income R5 | |||
LEOOX | 8.65 | N/A | N/A |
Lazard Enhanced Opportunities Open | |||
TRCSX | 17.18 | -0.08 | -0.46% |
T. Rowe Price Small-Cap Index I |